Cigna Group at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everyone. My name is Erin Wright. I'm lead Healthcare services analyst at Morgan Stanley. We're happy to have Cigna with us today. So with them, we have David Cordani, Chairman and CEO and we also have Giacobbe as well, heading up the IR effort there.
I -- just some of the important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, I will allow David to give some opening comments.
I'll be brief since she's allowing me, so I'll be brief and we get into Q&A. First, thanks for the opportunity to have a conversation today about Cigna, where we are and where we're going. A few headlines. One, we're pleased with our results. We have a continued track record of delivering strong balanced results and harnessing the breadth of our company, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |